OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials
作者
Dafna D. Gladman,Arthur Kavanaugh,Ade Adebajo,Juan Jesús Gómez-Reino,J. Wollenhaupt,Maurizio Cutolo,Georg Andreas Schett,Éric Lespessailles,M. McIlraith,C. Hu,C. J. Edwards,Charles A. Birbara,Philip J. Mease